{"chunk_id": "medquad__chunk_33367", "source": "medquad", "text": "sease that does not respond adequately to therapies and are left with significant disability. IBM is generally resistant to all therapies and its rate of progression appears to be unaffected by currently available treatments.\",NINDS,Inflammatory Myopathies\nwhat research (or clinical trials) is being done for Inflammatory Myopathies ?,\"The National Institutes of Health (NIH), through the collaborative efforts of its National Institute of Neurological Disorders and Stroke (NINDS), National Institu"}